Autopsy report · NCT00856089

Efficacy Study of Altabax to Clear Methicillin-resistant Staphylococcus Aureus (MRSA) Nasal Colonization

“Study is withdrawn and no one enrolled due to changes in personnel”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

Ochsner Health System

Sponsor type

University, hospital or other

Conditions

Methicillin-resistant Staphylococcus Aureus

Interventions

Retapamulin

Participants

0

Sites

2

Countries

United States

Trials that died the same way

• Sym004 Versus TAS-102 in Patients With mCRC
  “Study was withdrawn due to administrative reasons” (83% match in meaning)
• DELPhI Evaluation of Psychiatric Conditions
  “Study was withdrawn due to recruitment difficulties” (82% match in meaning)
• A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia
  “Study is being withdrawn for business reasons” (81% match in meaning)
• Maxi-Analgesic Osteoarthritis (OA) Study
  “The study was withdrawn for administrative reason” (80% match in meaning)
• Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma
  “Withdrawn: study halted prematurely, prior to enrollment of first participant” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.